Company / Profit Margin
KIORA PHARMACEUTICALS INC Profit Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
22.4%
FY2025
5-year range
-67102.9% / 22.4%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 6 years, ranging from -67102.9% in FY2021 to 22.4% in FY2025.
Based on SEC 10-K filings.
22.4% in FY2025 with a 5-year CAGR of +286.7%.
Improved from -264.2% to 22.4% over the past 5 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +286.7pp
- 10-Year Change
- -
Key checks
Key Insights
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 22.4% | - |
| FY2024 | - | - |
| FY2021 | -67102.9% | -25297.6% |
| FY2020 | -264.2% | +59.6% |
| FY2019 | -654.2% | +79.8% |
| FY2018 | -3243.5% | -62.7% |
| FY2017 | -1993.8% | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026